Gökhan Batur, Polyphor CEO
Polyphor mulls future after PhIII cancer program crashes
In 2018, Polyphor raised an $165 million IPO — a princely sum at the time — largely on the strength of two programs: a new type …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
